Cas:915278-11-4 Imidazo[1,2-a]pyrimidine, 6-bromo-, hydrobromide manufacturer & supplier

Chemical Name:Imidazo[1,2-a]pyrimidine, 6-bromo-, hydrobromide

CAS.NO:915278-11-4

Synonyms:6-BROMOIMIDAZO[1,2-A]PYRIMIDINE MONOHYDROBROMIDE;6-bromoimidazo[1,2-a]pyrimidine hydrogenbromide

Molecular Formula:C₆H₅Br₂N₃

Molecular Weight:278.93200

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:30.19000

Exact Mass:276.88500

LogP:2.44990

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 6-BROMOIMIDAZO[1,2-A]PYRIMIDINE MONOHYDROBROMIDE chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,6-bromoimidazo[1,2-a]pyrimidine hydrogenbromide physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,6-BROMOIMIDAZO[1,2-A]PYRIMIDINE MONOHYDROBROMIDE Use and application,6-BROMOIMIDAZO[1,2-A]PYRIMIDINE MONOHYDROBROMIDE technical grade,usp/ep/jp grade.

Related News: The drug, Imfinzi, when added to chemotherapy and the drugmaker��s other cancer drug tremelimumab, significantly improved the survival of patients without the disease progressing, when compared to chemotherapy alone, the company said. Imidazo[1,2-a]pyrimidine, 6-bromo-, hydrobromide manufacturer In April 2019, Glenmark had received approval from the Drugs Controller General of India (DCGI) for Remogliflozin Etabonate after successfully completing Phase-3 clinical trials. Imidazo[1,2-a]pyrimidine, 6-bromo-, hydrobromide supplier A week after the memo was released to employees, Reuters reported that the Justice Department had launched a criminal investigation focused on the Branchburg plant. That same day, May 27, Lilly reported to the U.S. Securities and Exchange Commission that it had received a subpoena from the department seeking documents related to the factory. Imidazo[1,2-a]pyrimidine, 6-bromo-, hydrobromide vendor A week after the memo was released to employees, Reuters reported that the Justice Department had launched a criminal investigation focused on the Branchburg plant. That same day, May 27, Lilly reported to the U.S. Securities and Exchange Commission that it had received a subpoena from the department seeking documents related to the factory. Imidazo[1,2-a]pyrimidine, 6-bromo-, hydrobromide factory Additional results from the trial with data on another goal of extending survival is expected in 2020, AstraZeneca said.